Sheldon L. Koenig
President and CEO, Director · Esperion Therapeutics, Inc.
- 2024
- Jul 13, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sheldon L. Koenig files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Benjamin Looker - $61K in ESPR purchases and sales in the last 12 months
- Benjamin Halladay - $51K in ESPR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sheldon L. Koenig?
Sheldon L. Koenig is a corporate insider, tracked as President and CEO, Director of Esperion Therapeutics, Inc. (ESPR). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Sheldon L. Koenig last file a Form 4?
The most recent primary Form 4 on record is dated 13 July 2026, one of 6 filings going back to 2024.
Has Sheldon L. Koenig been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($349K) across all tracked filings.
